Jeremy Sohn

Global Head, Digital Development and Business Development & Licensing

Novartis International AG, Cambridge (US)

Jeremy joined Novartis in 2015 as VP, Head of Digital Business Development & Licensing. In addition to serving in this role, Jeremy was appointed Global Head of Commercial Digital Medicines (2017) and Global Head of Digital Development (2016).
Jeremy is a serial software entrepreneur with more than 20 years of experience founding and managing healthcare and technology companies. Jeremy is a Board Member and Advisor to a number of digital health companies, including Pear Therapeutics, Science 37, MintHealth, Neural Analytics, and COTA. Prior to Novartis, Jeremy was Managing Director at MPM Capital where he led the firm's digital-health investment strategy. At MPM, Jeremy founded two companies, CentrosHealth (acquired by Clinical Ink) and TriNetX. In 2011, Jeremy co-founded GrapeVine. From 2007-2011, Jeremy was COO and VP, Strategy & Corporate Development for North Plains Systems, where he lead the company's growth and eventual sale to Accel-KKR. In 2000, he co-founded an open-source operating system company, Wasabi Systems.